Healthy Dose of Dialogue invites industry leaders to share fresh perspectives and engage in healthy dialogue about transformative marketplace trends and industry insights. Together, we‘re shaping a better future for people in healthcare.
Bonus: BigTopics in Small Doses: Transforming Healthcare in 2023. Three Catalysts to Watch
In this episode, we look to the far horizon, thinking about healthcare's fast-changing future and listening to industry insiders as they spotlight three major catalysts transforming care.
A Dose of Virtual First Health Care
Kate Brown, the leader of Mercer’s Center for Health Innovation, delivers an outlook and overview of virtual first care, its growth, and the diverse array of telehealth and digital solutions entering the market.
A Dose of Price Transparency and the Role of Pharmacists at the Point of Care
The cost of medications has skyrocketed and pharmacists are still filling prescriptions behind the counter instead of being used for their expertise to help patients at the point of care. In this episode, Dr. Edward Fotsch, CEO and founder of Gemini Health shares his perspectives with Salina Wong, Senior Director of Clinical Pharmacy Programs at Blue Shield of California, on how the industry can crack the code on drug cost savings through price transparency with lower cost alternatives, the critical role pharmacists can play as part of the overall care team, and the need for more competition to help reduce healthcare costs.
Bonus: BigTopics in Small Doses: Creating an Accessible, Affordable Prescription Drug Market
In Episode 6, we talk about the prescription drug market and the innovative approaches several companies are using to make inroads in drug affordability, accessibility, and effectiveness.
A Dose of Prescription Drug Disruption
Gina Guinasso, president at CivicaScript, talks about the exorbitant costs in today’s prescription drugs and how her organization – together with the industry – is leveling the playing field by distributing generic drugs directly to pharmacies. In her conversation with host Andy Chasin, Blue Shield of California’s Vice President of Federal Policy and Advocacy, she discusses the beginnings of CivicaScript, spotlights industry factors that have led to inflated drug costs, and outlines how transparent drug pricing and direct distribution to pharmacies can make drugs like insulin more affordable and accessible to patients across the country. Visit Civicarx.org to learn more about CivicaScript and the company’s mission to provide equitable pharmaceuticals at the lowest sustainable prices to patients.
A Dose of Digiceuticals and Mental Fitness
Sarah Hill, CEO at Healium, offers an inside look at the company’s virtual reality (VR) and augmented reality (AR) therapeutics for anxiety and stress. In her discussion with host Vic Tandon, Blue Shield of California’s director of health innovation product strategy, she points to the latest advances in wearable devices, breakthroughs in digital mental health solutions, and how immersive media represents a new and drugless aid for patients coping with stress. Visit tryhealium.com to learn more about Healium and how it combines wearables, neurofeedback, and immersive apps to improve mental fitness.
Great dialog on addressing the issues around Mental Health parity. Look forward to future topics
I appreciate the shift in mindset to reduce stigma on mental health care.
This is my first podcast and I’m glad that I listened. I learned much about this complex issue and I admire Patrick Kennedy for sharing his experiences.